Literature DB >> 26422199

Gamma-index method sensitivity for gauging plan delivery accuracy of volumetric modulated arc therapy.

Jong In Park1, Jong Min Park2, Jung-In Kim3, So-Yeon Park4, Sung-Joon Ye5.   

Abstract

PURPOSE: The aim of this study was to investigate the sensitivity of the gamma-index method according to various gamma criteria for volumetric modulated arc therapy (VMAT).
METHODS: Twenty head and neck (HN) and twenty prostate VMAT plans were retrospectively selected for this study. Both global and local 2D gamma evaluations were performed with criteria of 3%/3 mm, 2%/2 mm, 1%/2 mm and 2%/1 mm. In this study, the global and local gamma-index calculated the differences in doses relative to the maximum dose and the dose at the current measurement point, respectively. Using log files acquired during delivery, the differences in parameters at every control point between the VMAT plans and the log files were acquired. The differences in dose-volumetric parameters between reconstructed VMAT plans using the log files and the original VMAT plans were calculated. The Spearman's rank correlation coefficients (rs) were calculated between the passing rates and those differences.
RESULTS: Considerable correlations with statistical significances were observed between global 1%/2 mm, local 1%/2 mm and local 2%/1 mm and the MLC position differences (rs = -0.712, -0.628 and -0.581). The numbers of rs values with statistical significance between the passing rates and the changes in dose-volumetric parameters were largest in global 2%/2 mm (n = 16), global 2%/1 mm (n = 15) and local 2%/1 mm (n = 13) criteria.
CONCLUSION: Local gamma-index method with 2%/1 mm generally showed higher sensitivity to detect deviations between a VMAT plan and the delivery of the VMAT plan.
Copyright © 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dynamic log file; Gamma-index method; Pre-treatment quality assurance; Volumetric modulated arc therapy

Mesh:

Year:  2015        PMID: 26422199     DOI: 10.1016/j.ejmp.2015.08.005

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  8 in total

1.  Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Authors:  Dorota Maria Borowicz; Agnieszka Skrobała; Marta Kruszyna-Mochalska; Julian Malicki
Journal:  Radiol Oncol       Date:  2022-03-28       Impact factor: 4.214

2.  Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods.

Authors:  Dewayne L Defoor; Sotirios Stathakis; Joseph E Roring; Neil A Kirby; Panayiotis Mavroidis; Mohammad Obeidat; Nikos Papanikolaou
Journal:  J Appl Clin Med Phys       Date:  2017-06-06       Impact factor: 2.102

3.  Evaluation of Delta4DVH Anatomy in 3D Patient-Specific IMRT Quality Assurance.

Authors:  Du Tang; Zhen Yang; Xunzhang Dai; Ying Cao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

4.  Correlation of the gamma passing rates with the differences in the dose-volumetric parameters between the original VMAT plans and actual deliveries of the VMAT plans.

Authors:  Jong Min Park; Chang Heon Choi; Hong-Gyun Wu; Jung-In Kim
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

5.  Comparison of 3D and 2D gamma passing rate criteria for detection sensitivity to IMRT delivery errors.

Authors:  Dandan Zhang; Bin Wang; Guangshun Zhang; Charlie Ma; Xiaowu Deng
Journal:  J Appl Clin Med Phys       Date:  2018-06-15       Impact factor: 2.102

6.  Assessment of combined use of ArcCheck® detector and portal dosimetry for delivery quality assurance of head and neck and prostate volumetric-modulated arc therapy.

Authors:  Gilles Moliner; Lise Sorro; Rodolfe Verstraet; Paul Alexandre Daviau; Mélanie Casas; Bérengère Piron; Karine Dubois; Charles Debrigode; Corinne Barrau; Françoise Bons; Joël Greffier
Journal:  J Appl Clin Med Phys       Date:  2018-10-19       Impact factor: 2.102

7.  To propose adding index of achievement (IOA) to IMRT QA process.

Authors:  Dong-Su Kim; Siyong Kim; Seong-Hee Kang; Tae-Ho Kim; So-Hyun Park; Kyeong-Hyeon Kim; Min-Seok Cho; Dong-Seok Shin; Yu-Yun Noh; Jin-Beom Chung; Tae Suk Suh
Journal:  Radiat Oncol       Date:  2018-06-15       Impact factor: 3.481

8.  Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy.

Authors:  Dorota Maria Borowicz; Konstantin N Shipulin; Gennady V Mytsin; Agnieszka Skrobała; Piotr Milecki; Victor N Gayevsky; Vladimir Vondráček; Julian Malicki
Journal:  J Pers Med       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.